Guardant Health, Inc.
GH
$85.49
$1.471.75%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -38.58% | 7.18% | -4.98% | 14.28% | -3.02% |
| Total Depreciation and Amortization | 6.82% | -6.31% | -1.90% | -2.09% | -1.36% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 17.11% | 2.47% | 9.31% | 17.24% | -33.32% |
| Change in Net Operating Assets | 1,128.38% | 84.49% | 13.27% | -724.08% | 76.78% |
| Cash from Operations | 25.53% | 41.26% | 3.83% | 2.83% | -26.35% |
| Capital Expenditure | -169.06% | -83.22% | -26.69% | 76.38% | -349.51% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -20,355.78% | 20.00% | -101.63% | 945.14% | 110.12% |
| Cash from Investing | -6,207.09% | -34.75% | -103.52% | 2,776.20% | 103.57% |
| Total Debt Issued | 7,801.99% | 200.00% | -200.00% | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 9,684.52% | -59.72% | 1,102.73% | -84.73% | 25,045.00% |
| Repurchase of Common Stock | -136.29% | 69.48% | 87.74% | -654.17% | -179.16% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -1,021.67% | -144.54% | 139.85% | -20,677.97% | 290.32% |
| Cash from Financing | 16,802.05% | 166.69% | 102.43% | -2,177.68% | -1.73% |
| Foreign Exchange rate Adjustments | -28.71% | -156.88% | 21.22% | 145.60% | -189.21% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -335.33% | 32.77% | -139.27% | 397.03% | 83.10% |